Find out about the latest episodes, and listen here:

Emily Kate Stephens Emily Kate Stephens

Episode 74: Nancy Klimas, M.D. - Neuroimmunology

“So here comes the immune system. What are we doing for it? Well, it's inflammatory. It's over activated. And it's basically in hyperdrive. One of the 10 commandments of immunology is the immune system is antigen driven. It doesn't just turn on because it wants to turn on, it is turned on because something pushed the ‘on’ button.”

Read More
Emily Kate Stephens Emily Kate Stephens

Episode 72: Dr Thomas Chelimsky - autonomic dysfunction, migraine and trauma

“You have this chronic central nervous system influence on the body, such that there's inadequate return of blood to the brain… but the problem is not with the not with the veins, the problem is not with the blood return, the problem is not even with the nerves… The problem is with the central command system… so in this model, the idea would be that Covid is the trauma and that's it's turned on this switch, and Long Covid is the failure to turn off the switch.”

Read More
Emily Kate Stephens Emily Kate Stephens

Episode 71: Dr Andrew Klein - Iron and B12 deficiency

“The number one symptom that people present with when they've got Long Covid or pernicious anaemia or iron deficiency is fatigue. So that is across the board in all three conditions. And then the second most common symptom is shortness of breath, palpitations, dizziness, fainting, difficulty sleeping, brain fog, pins and needles joint pain, depression and anxiety…”

Read More
Emily Kate Stephens Emily Kate Stephens

Episode 70: Benjamin Abramoff M.D. - Serotonin Depletion

“They found that the strongest signal was coming from serotonin. Peripheral serotonin levels were very similar between those who are acutely active with Covid and those who had Long Covid and much lower than those who had recovered from Covid and did not have persistent symptoms.”

Read More
Emily Kate Stephens Emily Kate Stephens

Episode 69: Prof. Tim Henrich - Viral persistence and T cell dysregulation

“We are seeing viral persistence in tissues over many years after initial infection and the immune system is not able to completely clear this out. And so now we have to figure out how either we a) can get the immune system to clear this all out, or can we use other modalities - antivirals, monoclonal antibodies, immune-boosting modification, things like that, that will actually help purge these kind of persistent infected cells that we're observing in tissue.”

Read More
Noreen Jameel Noreen Jameel

Episode 68: Dr Steven Allder - Re:Cognition Health

“60 to 70% of the Long Covid patients with that specific people phenotype - that type of pattern of symptoms - got quantifiable, abnormal pain PET scans, which puts the problem, I think, really in the brain.”

Read More
Emily Kate Stephens Emily Kate Stephens

Episode 67: Prof. Andrew Shaw – Antibody gap

“We're going to look at our antibody spectrum to do a diagnostic accuracy study. What I expect to find is there'll be groups of patients where some of them have holes around the onset of the of the Long Covid symptoms. “

Read More
Noreen Jameel Noreen Jameel

Episode 66: Prof. Danny Altmann Returns

“When we talk about Long Covid on planet Earth, I think the lower estimates are about 60 million and the upper estimates are at 400 million globally. It's not a disease of the wealthy worried well in the UK or the US or whatever, it's a disease of six to 10% of everybody on planet earth has ever had COVID-19, no matter where they are. So if the stakes are that high, why on earth can't we regain some of that battle spirit and momentum? I think it does come into kind of policy and politics.”

Read More
Emily Kate Stephens Emily Kate Stephens

Episode 64: Michael Peluso, M.D. – Viral reservoirs & MAB trial

“The first year of this was recognising the problem and getting people to buy into that... The second year of this was describing who was most likely to get this condition. The third year of this was laying out potential biology. The current era of this now needs to be proving that each of those mechanisms is or is not driving this and… you actually have to intervene on those pathways to see if you can change either a biological measurement or change how people feel. What that means to us is doing trying to do these intense proof of concept, experimental medicine type studies, where we identify a target pathway that we think it is contributing, then we try to alter it by giving an investigational treatment and we see what happens and whether our hypothesis was correct.”

Read More
Emily Kate Stephens Emily Kate Stephens

Episode 62: Prof. Harlan Krumholz - Vibrations, LISTEN, and Paxlovid studies

“Our reward system is - how many papers, how many citations, how many grants… and what enamoured me as I got started in my career was the idea that none of that really matters if you haven't made a difference in people's lives. So the question really is - what's the value of the information you're producing? And how can you do it in a way that that makes a difference?”

Read More
Emily Kate Stephens Emily Kate Stephens

Episode 61: Dr Leo Galland – A functional approach

“The conventional model is trying to identify what disease does this person have, and then you treat the disease. Well, that may work in some situations… but there are many situations involving chronic illness in which that doesn't work. And I've evolved and taught other approaches to diagnosis, something that I call person-centred diagnosis.”

Read More
Emily Kate Stephens Emily Kate Stephens

Episode 60: Research-Aid Networks – all about the acid-base

“We’re trying to develop clinical trials ourselves, to look at this combination of clinical point testing, where we can actually do that very robust analysis of saying, what's going on in terms of blood gases, what's going on in terms of bicarbonate, what's going on in terms of pH? How is that affecting patients at rest and in movement, and how does that correlate with symptoms?”

Read More
Emily Kate Stephens Emily Kate Stephens

Episode 59: Dr Wes Ely - Treating with humanity

“I would word this as a massive public health problem… crisis that most of the world is yawning through and sleepwalking through. I think people are sleepwalking through this because it's too invisible.”

Read More
Noreen Jameel Noreen Jameel

Episode 57: Lavanya Visvabharathy - Publishing the science

Publishing in scientific journals is a challenging process due to fierce competition, limited resources, lack of networks and mentorship, bias and subjectivity in peer review, leading to high rejection rates. Addressing these obstacles requires collective efforts to foster inclusivity, collaboration, and support systems for all researchers.

Read More
#health #covid #longcovid #brain Noreen Jameel #health #covid #longcovid #brain Noreen Jameel

Episode 56: Dr Jim Jackson - Clearing the Fog

Dr Jim Jackson, research professor of Medicine and Psychiatry at Vanderbilt University Medical Centre, does not believe that Long Covid is all in your mind, but he has found that treating the brain, as if it has a brain injury, can help Long Covid recovery. In this week’s episode Dr Jackson explains his clinical experience of the neurological impact of Long Covid from brain fog to anxiety, PTSD to OCD. He discusses the power of cognitive rehabilitation (which should be viewed as physiotherapy for the brain) and tells us about his book “Clearing the Fog: A practical guide to surviving and thriving with Long Covid”. And he talks us through the power of talking to others within the community: his support groups have been a hugely impactful for sufferers enabling them to learn from each other, learn how to advocate for themselves, and give them hope.

Read More
Emily Kate Stephens Emily Kate Stephens

Episode 54: Dr Bhupesh Prusty – Molecular Virologist

“We have always been focusing to find something which is detectable and when we talk about something detectable we are actually talking about something which is produced more - this is called as gain of function. But…sometimes loss of function is also important.. there is one switch which is where we are actually losing something from ourselves.”

Read More
Emily Kate Stephens Emily Kate Stephens

Episode 51: Akiko Iwasaki – Immunobiologist

“There are so many questions that are unanswered about Long Covid. We're just scratching the surface of this disease.. that's why it's dangerous to come to a conclusion at this stage - because we know so little. It doesn't mean that we aren't looking. We're looking very hard. I'm obsessed about trying to understand this disease, and many scientists are, so hopefully will chip away at this disease. But we need to be open minded and humble about what's going on.”

Read More